Acadia Pharmaceuticals
ACAD
ACAD
186 hedge funds and large institutions have $1.79B invested in Acadia Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 59 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 196 → 186 (-10)
18% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 49
35% less capital invested
Capital invested by funds: $2.74B → $1.79B (-$960M)
Holders
186
Holding in Top 10
2
Calls
$47M
Puts
$39.6M
Top Buyers
| 1 | +$47.1M | |
| 2 | +$30.5M | |
| 3 | +$25.2M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$14.5M |
| 5 |
O
OrbiMed
New York
|
+$14.4M |
Top Sellers
| 1 | -$62.2M | |
| 2 | -$54.2M | |
| 3 | -$48.7M | |
| 4 |
HM
HealthCor Management
New York
|
-$31M |
| 5 |
JPMorgan Chase & Co
New York
|
-$21.8M |